Full-Text Search:
Home|About CNKI|User Service|中文
Add to Favorite Get Latest Update

Effect observation of combination therapy with nimodipine and oxiracetam of patients with type 2 diabetes mellitus combined with mild vascular cognitive impairment

Zhong Yihua;Tang Xianjun;Nan Yingyu;Department of Neurology,Chongqing Tumor Institute;  
Objective To observe the efficacy of combination therapy with nimodipine and oxiracetam for type 2diabetes mellitus(T2DM)patients with mild vascular cognitive impairment(mVCI).`Methods Seventy-two T2MD-mVCI patients were divided into control group and observation group and each group was 36 cases.Control group was given routine treatment and nimodipine 40 mg,3times every day;observation group was given oxiracetam 800 mg,2times every day;the treatment course was 6months.fasting blood glucose(FBG),2hpostprandial hyperglycemia(2hPBG),glycosylated hemoglobin A1C(HbA1C),C peptide level were recorded and MoCA cognitive function scale was used to evaluated patients cognitive function of each group before and after the treatment.Results Before the treatment,both two groups with C peptide level were declined and mild cognitive impairment,there were no statistically significant differences(P0.05).After the treatment,C peptide level,MoCA scores and cognitive function subscores of memory,executive,attention were significantly higher than before(P0.05);the observation group compared with the control group improved significantly(P0.01).Conclusion Combination therapy with nimodipine and oxiracetam could significantly improve cognitive function in patients with T2DM-mVCI,its efficacy is superior to nimodipine.
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©CNKI All Rights Reserved